Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel T Eitzman

Showing results (1-10 of 65) with videos related to

Pageof 7
Sort By:
Atherosclerosis|May 2, 2013
Acute myocardial infarction leads to acceleration of atherosclerosisHui Wang, Daniel T Eitzman
European Journal of Case Reports in Internal Medicine|June 12, 2023
Resolution of Sickle Cell Crisis Following Administration of AmiodaronePaul Silaghi, Daniel T Eitzman
Recent Patents on Cardiovascular Drug Discovery|November 21, 2009
Targeting MCP-1 to reduce vascular complications of obesityMiina K Ohman, Daniel T Eitzman
Current Opinion in Hematology|June 25, 2009
Animal models of thrombosisPeter F Bodary, Daniel T Eitzman
Current Drug Targets|September 28, 2007
Plasminogen activator inhibitor-1 in vascular thrombosisRandal J Westrick, Daniel T Eitzman
Current Pharmaceutical Design|May 22, 2013
Leptin in thrombosis and atherosclerosisHui Wang, Wei Luo, Daniel T Eitzman
Journal of Thrombosis and Haemostasis : JTH|April 6, 2026
Sickle Hemoglobin Promotes Venous Thrombosis Through Procoagulant Activity and Is Targetable by Hemoglobinase TherapyJintao Wang, Paul Silaghi, Daniel T Eitzman
Arteriosclerosis, Thrombosis, and Vascular Biology|August 23, 2014
Imaging body fat: techniques and cardiometabolic implicationsH Wang, Y E Chen, Daniel T Eitzman
Trends in Cardiovascular Medicine|May 8, 2007
Alpha-galactosidase A in vascular diseasePeter F Bodary, James A Shayman, Daniel T Eitzman
British Journal of Haematology|November 17, 2021
Interleukin-1 receptor antagonism leads to improved anaemia in a murine model of sickle cell disease and is associated with reduced ex vivo platelet-mediated erythrocyte sicklingJessica Venugopal, Jintao Wang, Chiao Guo, et al.
Pageof 7

Showing results (1-10 of 65) with videos related to

Sort By:
Pageof 7
Atherosclerosis|May 2, 2013
Acute myocardial infarction leads to acceleration of atherosclerosisHui Wang, Daniel T Eitzman
European Journal of Case Reports in Internal Medicine|June 12, 2023
Resolution of Sickle Cell Crisis Following Administration of AmiodaronePaul Silaghi, Daniel T Eitzman
Recent Patents on Cardiovascular Drug Discovery|November 21, 2009
Targeting MCP-1 to reduce vascular complications of obesityMiina K Ohman, Daniel T Eitzman
Current Opinion in Hematology|June 25, 2009
Animal models of thrombosisPeter F Bodary, Daniel T Eitzman
Current Drug Targets|September 28, 2007
Plasminogen activator inhibitor-1 in vascular thrombosisRandal J Westrick, Daniel T Eitzman
Current Pharmaceutical Design|May 22, 2013
Leptin in thrombosis and atherosclerosisHui Wang, Wei Luo, Daniel T Eitzman
Journal of Thrombosis and Haemostasis : JTH|April 6, 2026
Sickle Hemoglobin Promotes Venous Thrombosis Through Procoagulant Activity and Is Targetable by Hemoglobinase TherapyJintao Wang, Paul Silaghi, Daniel T Eitzman
Arteriosclerosis, Thrombosis, and Vascular Biology|August 23, 2014
Imaging body fat: techniques and cardiometabolic implicationsH Wang, Y E Chen, Daniel T Eitzman
Trends in Cardiovascular Medicine|May 8, 2007
Alpha-galactosidase A in vascular diseasePeter F Bodary, James A Shayman, Daniel T Eitzman
British Journal of Haematology|November 17, 2021
Interleukin-1 receptor antagonism leads to improved anaemia in a murine model of sickle cell disease and is associated with reduced ex vivo platelet-mediated erythrocyte sicklingJessica Venugopal, Jintao Wang, Chiao Guo, et al.
Pageof 7